ROANOKE, Va. and FRANKLIN LAKES, N.J., Jan. 22, 2025 /PRNewswire/ -- Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...

ROANOKE, Va. and FRANKLIN LAKES, N.J., Jan. 22, 2025 /PRNewswire/ -- Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, ...

On August 9 the U.S. Food and Drug Administration (FDA) announced it had approved an epinephrine spray for emergency treatment of severe allergic reactions and anaphylaxis for adults and children over ...

The Food and Drug Administration has just approved a first-of-its-kind needle-free alternative to EpiPens or epinephrine autoinjectors. Neffy, a nasal spray that delivers a dose of epinephrine, is the ...

SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY) (Nasdaq: SPRY), a biopharmaceutical company dedicated to the development of products to better protect patients from ...

The Food and Drug Administration has approved ARS Pharmaceuticals’ nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions, the agency said on Friday. The ...